Identification of Genes Potentially Regulated by Human Polynucleotide Phosphorylase (hPNPaseold-35) Using Melanoma as a Model

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Sokhi, Upneet K ^a   Bacolod, Manny D ^a,b   Dasgupta, Santanu ^a,b   Emdad, Luni ^a,b,c   Das, Swadesh K ^a,b   Dumur, Catherine I ^a   Miles, Michael F ^a,b,c   Sarkar, Devanand ^a,b,c   Fisher, Paul B ^a,b,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYRIBONUCLEOTIDE NUCLEOTIDYLTRANSFERASE;

ARTICLE; CELL CYCLE REGULATION; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE CONTROL; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC IDENTIFICATION; HUMAN; HUMAN CELL; INFLAMMATION; MELANOMA CELL; WOUND HEALING;

ADENOVIRIDAE; CELL LINE, TUMOR; CLONING, MOLECULAR; DATABASES, GENETIC; DNA, COMPLEMENTARY; EXORIBONUCLEASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MELANOMA;

EID: 84885459349     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076284     Document Type: Article

References (58)

1. Arraiano C, Andrade J, Domingues S, Guinote I, Malecki M, et al. (2010) The critical role of RNA processing and degradation in the control of gene expression. FEMS Microbiol Rev 34: 883-923.
2. Deutscher MP, Li Z, (2001) Exoribonucleases and their multiple roles in RNA metabolism. Prog Nucleic Acid Res Mol Biol 66: 67-105.
3. Deutscher MP, (1993) Ribonuclease multiplicity, diversity, and complexity. J Biol Chem 268: 13011-13014.
4. Andrade J, Pobre V, Silva I, Domingues S, Arraiano C, (2009) The role of 3′-5′ exoribonucleases in RNA degradation. Prog Mol Biol Transl Sci 85: 187-229.
5. Ibrahim H, Wilusz J, Wilusz CJ, (2008) RNA recognition by 3′-to-5′ exonucleases: the substrate perspective. Biochim Biophys Acta 1779(4): 256-265.
6. Leszczyniecka M, DeSalle R, Kang DC, Fisher PB, (2004) The origin of polynucleotide phosphorylase domains. Mol Phylogenet Evol 31: 123-130.
7. Leszczyniecka M, Kang DC, Sarkar D, Su ZZ, Holmes M, et al. (2002) Identification and cloning of human polynucleotide phosphorylase, hPNPaseold-35, in the context of terminal differentiation and cellular senescence. Proc Natl Acad Sci U S A 99: 16636-16641.
8. Leszczyniecka M, Su ZZ, Kang DC, Sarkar D, Fisher PB, (2003) Expression regulation and genomic organization of human polynucleotide phosphorylase, hPNPaseold-35, a Type I interferon inducible early response gene. Gene 316: 143-156.
9. Chen H, Rainey R, Balatoni C, Dawson D, Troke J, et al. (2006) Mammalian polynucleotide phosphorylase is an intermembrane space RNase that maintains mitochondrial homeostasis. Mol Cell Biol 26: 8475-8487.
10. Rainey R, Glavin J, Chen H, French S, Teitell MA, et al. (2006) A new function in translocation for the mitochondrial i-AAA protease Yme1: import of polynucleotide phosphorylase into the intermembrane space. Mol Cell Biol 26: 8488-8497.
11. Sarkar D, Leszczyniecka M, Kang DC, Lebedeva IV, Valerie K, et al. (2003) Down-regulation of Myc as a potential target for growth arrest induced by human polynucleotide phosphorylase (hPNPaseold-35) in human melanoma cells. J Biol Chem 278: 24542-24551.
12. Das SK, Sokhi UK, Bhutia SK, Azab B, Su ZZ, et al. (2010) Human polynucleotide phosphorylase selectively and preferentially degrades microRNA-221 in human melanoma cells. Proc Natl Acad Sci U S A 107: 11948-11953.
13. Sarkar D, Park ES, Barber G, Fisher PB, (2007) Activation of double-stranded RNA dependent protein kinase, a new pathway by which human polynucleotide phosphorylase (hPNPaseold-35) induces apoptosis. Cancer Res 67: 7948-7953.
14. Chan I, Lebedeva IV, Su ZZ, Sarkar D, Valerie K, et al. (2008) Progression elevated gene-3 promoter (PEG-Prom) confers cancer cell selectivity to human polynucleotide phosphorylase (hPNPaseold-35)-mediated growth suppression. J Cell Physiol 215: 401-409.
15. Van Maerken T, Sarkar D, Speleman F, Dent P, Weiss W, et al. (2009) Adenovirus-mediated hPNPaseold-35 gene transfer as a therapeutic strategy for neuroblastoma. J Cell Physiol 219: 707-715.
16. Das SK, Bhutia SK, Sokhi UK, Dash R, Azab B, et al. (2011) Human polynucleotide phosphorylase (hPNPaseold-35): an evolutionary conserved gene with an expanding repertoire of RNA degradation functions. Oncogene 30: 1733-1743.
17. Sarkar D, Park ES, Fisher PB, (2006) Defining the mechanism by which IFN-beta dowregulates c-myc expression in human melanoma cells: pivotal role for human polynucleotide phosphorylase (hPNPaseold-35). Cell Death Differ 13: 1541-1553.
18. Sarkar D, Fisher PB, (2006) Human polynucleotide phosphorylase (hPNPaseold-35): an RNA degradation enzyme with pleiotrophic biological effects. Cell cycle 5: 1080-1084.
19. Sarkar D, Fisher PB, (2006) Polynucleotide phosphorylase: an evolutionary conserved gene with an expanding repertoire of functions. Pharmacology therapeutics 112: 243-263.
20. Sokhi UK, Das SK, Dasgupta S, Emdad L, Shiang R, et al. (2013) Human polynucleotide phosphorylase (hPNPaseold-35): should I eat you or not- that is the question? Advances in Cancer Research 119 (in press).
21. Sarkar D, Lebedeva IV, Emdad L, Kang DC, Baldwin AS, et al. (2004) Human polynucleotide phosphorylase (hPNPaseold-35): a potential link between aging and inflammation. Cancer Res 64: 7473-7478.
22. Sarkar D, Fisher PB, (2006) Molecular mechanisms of aging-associated inflammation. Cancer Lett 236: 13-23.
23. Wang G, Chen H, Oktay Y, Zhang J, Allen E, et al. (2010) PNPASE regulates RNA import into mitochondria. Cell 142: 456-467.
24. Wang G, Shimada E, Koehler CM, Teitell MA, (2011) PNPASE and RNA trafficking into mitochondria. Biochim Biophys Acta 1819: 998-1007.
25. Nagaike T, Suzuki T, Katoh T, Ueda T, (2005) Human mitochondrial mRNAs are stabilized with polyadenylation regulated by mitochondria-specific poly(A) polymerase and polynucleotide phosphorylase. J Biol Chem 280: 19721-19727.
26. Slomovic S, Schuster G, (2008) Stable PNPase RNAi silencing: its effect on the processing and adenylation of human mitochondrial RNA. RNA 14: 310-323.
27. Yu Y, Chou R, Wu C, Wang Y, Chang W, et al. (2012) Nuclear EGFR Suppresses Ribonuclease Activity of Polynucleotide Phosphorylase through DNAPK-mediated Phosphorylation at Serine 776. J Biol Chem 287: 31015-31026.
28. Chen H, Koehler CM, Teitell MA, (2007) Human polynucleotide phosphorylase: location matters. Trends Cell Biol 17: 600-608.
29. Giovanella BC, Stehlin JS, Williams LJ Jr, (1974) Heterotransplantation of human malignant tumors in "nude" thymusless mice. II. Malignant tumors induced by injection of cell cultures derived from human solid tumors. J Natl Cancer Inst 52(3): 921-30.
30. Huberman E, Heckman C, Langenbach R, (1979) Stimulation of differentiated functions in human melanoma cells by tumor-promoting agents and dimethyl sulfoxide. Cancer Res 39: 2618-2624.
31. Fisher PB, Prignoli DR, Hermo H, Weinstein IB, Pestka S, (1985) Effects of combined treatment with interferon and mezerein on melanogenesis and growth in human melanoma cells. J Interferon Res 5: 11-22.
32. Herlyn M, Thurin J, Balaban G, Bennicelli JL, Herlyn D, et al. (1985) Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res 45: 5670-5676.
33. Balaban G, Herlyn M, Guerry D IV, Bartolo R, Koprowski H, et al. (1984) Cytogenetics of human malignant melanoma and premalignant lesions. Cancer Genet Cytogenet 11: 429-439.
34. Li G, Schaider H, Satyamoorthy K, Hanakawa Y, Hashimoto K, et al. (2001) Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development. Oncogene 20(56): 8125-35.
35. Jiang H, Lin J, Su ZZ, Herlyn M, Kerbel RS, et al. (1995) The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene 10(9): 1855-64.
36. Dumur CI, Ladd AC, Wright HV, Penberthy LT, Wilkinson DS, et al. (2009) Genes involved in radiation therapy response in head and neck cancers. Laryngoscope 119: 91-101.
37. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biology 5: R80.
38. Gatta V, Drago D, Fincati K, Valenti MT, Dalle Carbonare L, et al. (2011) Microarray analysis on human neuroblastoma cells exposed to aluminum, β (1-42)-amyloid or the β (1-42)-amyloid aluminum complex. PloS One 6(1): e15965.
39. Redmond LC, Dumur CI, Archer KJ, Haar JL, Lloyd JA, (2008) Identification of erythroid-enriched gene expression in the mouse embryonic yolk sac using microdissected cells. Developmental Dynamics 237: 436-446.
40. Chen J, Bardes EE, Aronow BJ, Jegga AG, (2009) ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 37: W305-W311.
41. Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, et al. (2010) The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Research 38: W214-W220.
42. Oliveros J.C. (2007) VENNY. An interactive tool for comparing lists with Venn Diagrams. Available: http://bioinfogp.cnb.csic.es/tools/venny/index.html. Accessed 2013 Aug 29.
43. Arsenijevic D, Onuma H, Pecqueur C, Raimbault S, Manning BS, et al. (2000) Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 26(4): 435-439.
44. Vedrenne V, Gowher A, De Lonlay P, Nitschke P, Serre V, et al. (2012) Mutation in PNPT1, which encodes a polyribonucleotide nucleotidyltransferase, impairs RNA import into mitochondria and causes respiratory-chain deficiency. Am J Hum Genet 91(5): 912-918.
45. Gottlieb E, Armour SM, Harris MH, Thompson CB, (2003) Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis. Cell Death Differ 10(6): 709-717.
46. Huynh KM, Kim G, Kim DJ, Yang SJ, Park SM, et al. (2009) Gene expression analysis of terminal differentiation of human melanoma cells highlights global reductions in cell cycle-associated genes. Gene 433: 32-39.
47. Staudt MR, DePass AL, Sarkar D, Fisher PB, (2009) Model cell culture system for defining the molecular and biochemical events mediating terminal differentiation of human melanoma cells. J Cell Physiol 218: 304-314.
48. Obaya MM, Mateyak MK, Obaya AJ, Adachi S, Sedivy JM, (1997) Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination; Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ 8(10): 1039-1048.
49. Bush A, Mateyak M, Dugan K, Obaya A, Adachi S, et al. (1998) c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets. Genes Dev 12(24): 3797-3802.
50. Yen TJ, Compton DA, Wise D, Zinkowski RP, Brinkley BR, et al. (1991) CENP-E, a novel human centromere-associated protein required for progression from metaphase to anaphase. EMBO J 10(5): 1245-1254.
51. Tanudji M, Shoemaker J, L'Italien L, Russell L, Chin G, et al. (2004) Gene silencing of CENP-E by small interfering RNA in HeLa cells leads to missegregation of chromosomes after a mitotic delay. Mol Biol Cell 15(8): 3771-3781.
52. Scholzen T, Gerdes J, (2000) The Ki-67 protein: From the known and the unknown. J Cell Physiol 182: 311-322.
53. Bullwinkel J, Baron-Lühr B, Lüdemann A, Wohlenberg C, Gerdes J, et al. (2006) Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J Cell Physiol 206: 624-635.
54. Rahmanzadeh R, Hüttmann G, Gerdes J, Scholzen T, (2007) Chromophore-assisted light inactivation of pKi-67 leads to inhibition of ribosomal RNA synthesis. Cell Prolif 40(3): 422-430.
55. Anandasabapathy N, Ford GS, Bloom D, Holness C, Paragas V, et al. (2003) GRAIL: An E3 Ubiquitin Ligase that Inhibits Cytokine Gene Transcription Is Expressed in Anergic CD4+ T Cells. Immunity 18: 535-547.
56. Hahm S, Mizuno TM, Wu TJ, Wisor JP, Priest CA, et al. (1999) Targeted Deletion of the Vgf Gene Indicates that the Encoded Secretory Peptide Precursor Plays a Novel Role in the Regulation of Energy Balance. Neuron 23: 537-548.
57. Rizzi R, Bartolomucci A, Moles A, D'Amato F, Sacerdote P, et al. (2008) The VGF-derived peptide TLQP-21: A new modulatory peptide for inflammatory pain. Neurosci Lett 441: 129-133.
58. Ferri G, Noli B, Brancia C, D'Amato F, Cocco C, (2011) VGF: An inducible gene product, precursor of a diverse array of neuro-endocrine peptides and tissue-specific disease biomarkers. J Chem Neuroanat 42: 249-261.